highperformr logo

AZTherapies's Overview

Total employees9
HeadquartersBoston
Founded2011

AZTherapies, Inc. is a private, clinical-stage biopharmaceutical company headquartered in Boston, MA. It focuses on developing innovative treatments for neurodegenerative diseases, particularly Alzheimer's disease. The company's approach targets critical underlying mechanisms such as neuroinflammation and mitochondrial dysfunction. Its lead candidate, ALZT-OP1, aimed to combine two reformulated existing drugs to address these pathways, though its Phase 3 COGNITE trial did not meet its primary endpoints in 2021. The company continues to explore therapeutic options in neurodegeneration.

Where is AZTherapies's Headquarters?

HQ Function

The headquarters serves as the central location for corporate management, strategic planning, clinical development oversight, research collaborations, and administrative functions.

Notable Features:

Located in a major office building in Boston's Financial District, providing access to a dense network of research institutions, talent, and potential partners. Specific architectural details of their suite are not publicly emphasized.

Work Culture:

Likely fosters a focused, science-driven, and resilient work environment, characteristic of clinical-stage biotech companies. Emphasis would be on innovation, rigorous research, and addressing complex medical challenges in neurodegenerative diseases.

HQ Significance:

The Boston location provides strategic advantages, including proximity to world-class academic institutions, hospitals, a rich talent pool in life sciences, and a vibrant venture capital and investment community.

Values Reflected in HQ: The choice of a central, professional location in a leading biotech hub suggests a commitment to innovation, collaboration, and maintaining a strong presence within the scientific and business community.

Location:

AZTherapies, Inc. is primarily based in the United States, with its operations centered at its Boston headquarters. While its clinical trials historically involved international sites to ensure diverse patient populations, its core R&D, strategic, and administrative functions are managed from the US. The company's therapeutic focus on Alzheimer's disease addresses a global health challenge.

Street Address:

60 State Street, Suite 700

City:

Boston

State/Province:

MA

Country:

USA

AZTherapies's Global Presence

Buying Intent Signals for AZTherapies

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of AZTherapies

As of April 2025, AZTherapies' leadership includes:

David R. Elmaleh, PhD - Founder, Chairman, and Chief Executive Officer
Marc de Somer, MD - Chief Medical Officer
Miroslav Cuturic, MD, JD - Vice President, Head of Clinical Development

Investors of AZTherapies

AZTherapies has been backed by several prominent investors over the years, including:

Morningside Ventures
RA Capital Management
Adage Capital Management
Allergan (now part of AbbVie)
Mass Medical Angels (MMA)
Country EBasket

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

No major public announcements regarding executive hires or departures at AZTherapies, Inc. have been identified in the last 12 months. The company's leadership team appears to have remained consistent during this period.

Technology (Tech Stack) used by AZTherapies

Discover the tools AZTherapies uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

AZTherapies Email Formats and Examples

AZTherapies, Inc. likely uses a standard professional email format. A common pattern observed for companies of its profile is the first initial followed by the last name.

[first_initial][last]@aztherapies.com

Format

delmaleh@aztherapies.com

Example

70%

Success rate

News and media

PR NewswireMarch 28, 2023

AZTherapies Announces Publication Highlighting the Unique Mechanism of Action of its Lead Drug Candidate, ALZT-OP1, in Alzheimer's Disease

AZTherapies announced a publication in the Journal of Alzheimer's Disease detailing preclinical findings that support the multimodal mechanism of action for ALZT-OP1. The research suggests ALZT-OP1's potential to target neuroinflammation and amyloid-beta pathology, key factors in Alzheimer's disease progression....more

AZTherapies, Inc. Press ReleaseJuly 29, 2021

AZTherapies Provides Update on Phase 3 COGNITE Alzheimer’s Disease Trial of ALZT-OP1

AZTherapies announced that its Phase 3 COGNITE trial of ALZT-OP1 in early Alzheimer's disease did not meet its co-primary efficacy endpoints. The company stated it would continue to analyze the data to understand the results fully....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including AZTherapies, are just a search away.